John Kress is a Respiratory physician affiliated with University of Chicago. OpenAlex indexes 346 publications with 28,170 citations (h-index 57); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5841 S Maryland Ave
Chicago, IL 606371443
Telephone
888-824-0200Registry record last updated 24 Oct 2022.
Clinical trials
- Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
Sponsor: University of Chicago
- Vasopressor SAT Study
Sponsor: University of Chicago
- Vasoactive Drugs in Intensive Care Unit
Sponsor: University of Chicago
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
74.1%Corticosteroid30.9%Trelegy Ellipta88%Budesonide-Formoterol Fumarate13%Part D<11 patientsbeta2-Adrenergic Agonist23.7%Albuterol Sulfate Hfa74%Ventolin Hfa26%Part D<11 patients+ 3 more classes in this area
Cardiovascular
14.6%Statin4.4%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker3.6%Amlodipine Besylate100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
8.3%Proton pump inhibitor4.7%Omeprazole100%Part D<11 patientsPotassium supplement3.6%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2002–2005 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial
The Lancet Respiratory Medicine
2023 - Temperature Trajectory Subphenotypes Correlate With Immune Responses in Patients With Sepsis
Critical Care Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Mary Rinella, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”